These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 33618602)
1. Challenging inflammatory process at molecular, cellular and in vivo levels via some new pyrazolyl thiazolones. Elzahhar PA; Alaaeddine RA; Nassra R; Ismail A; Labib HF; Temraz MG; Belal ASF; El-Yazbi AF J Enzyme Inhib Med Chem; 2021 Dec; 36(1):669-684. PubMed ID: 33618602 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents. Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives. Chaaban I; Rizk OH; Ibrahim TM; Henen SS; El-Khawass EM; Bayad AE; El-Ashmawy IM; Nematalla HA Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046 [TBL] [Abstract][Full Text] [Related]
4. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids. Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, biological evaluation, and computational studies of novel thiazolo-pyrazole hybrids as promising selective COX-2 inhibitors: Implementation of apoptotic genes expression for ulcerogenic liability assessment. Marzouk AA; Taher ES; Shaykoon MSA; Lan P; Abd-Allah WH; Aboregela AM; El-Behairy MF Bioorg Chem; 2021 Jun; 111():104883. PubMed ID: 33865053 [TBL] [Abstract][Full Text] [Related]